DK2188268T3 - Substituerede piperazinylpyraziner og pyridiner som 5-HT7-receptorantagonister - Google Patents
Substituerede piperazinylpyraziner og pyridiner som 5-HT7-receptorantagonisterInfo
- Publication number
- DK2188268T3 DK2188268T3 DK08798144.5T DK08798144T DK2188268T3 DK 2188268 T3 DK2188268 T3 DK 2188268T3 DK 08798144 T DK08798144 T DK 08798144T DK 2188268 T3 DK2188268 T3 DK 2188268T3
- Authority
- DK
- Denmark
- Prior art keywords
- piperazinylpyrazines
- pyridines
- substituted
- receptor antagonists
- antagonists
- Prior art date
Links
- HCGFLVDMFDHYJD-UHFFFAOYSA-N 2-piperazin-1-ylpyrazine Chemical class C1CNCCN1C1=CN=CC=N1 HCGFLVDMFDHYJD-UHFFFAOYSA-N 0.000 title 1
- 108091005436 5-HT7 receptors Proteins 0.000 title 1
- 150000003222 pyridines Chemical class 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96834407P | 2007-08-28 | 2007-08-28 | |
| US4875208P | 2008-04-29 | 2008-04-29 | |
| PCT/US2008/073543 WO2009029439A1 (en) | 2007-08-28 | 2008-08-19 | Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2188268T3 true DK2188268T3 (da) | 2011-10-03 |
Family
ID=39873874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08798144.5T DK2188268T3 (da) | 2007-08-28 | 2008-08-19 | Substituerede piperazinylpyraziner og pyridiner som 5-HT7-receptorantagonister |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8048884B2 (da) |
| EP (1) | EP2188268B1 (da) |
| JP (1) | JP5290293B2 (da) |
| KR (1) | KR101148616B1 (da) |
| CN (1) | CN101790522B (da) |
| AR (1) | AR068111A1 (da) |
| AT (1) | ATE520673T1 (da) |
| AU (1) | AU2008293715B2 (da) |
| BR (1) | BRPI0816468A2 (da) |
| CA (1) | CA2694911C (da) |
| CY (1) | CY1111848T1 (da) |
| DK (1) | DK2188268T3 (da) |
| EA (1) | EA017809B1 (da) |
| HR (1) | HRP20110624T1 (da) |
| MX (1) | MX2010002352A (da) |
| PE (1) | PE20090629A1 (da) |
| PL (1) | PL2188268T3 (da) |
| PT (1) | PT2188268E (da) |
| SI (1) | SI2188268T1 (da) |
| TW (1) | TW200914020A (da) |
| WO (1) | WO2009029439A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI118473B (fi) | 2006-02-17 | 2007-11-30 | Outotec Oyj | Menetelmä kuparin talteenottamiseksi kuparisulfidimalmista |
| CA2699674C (en) * | 2007-10-12 | 2013-07-16 | Eli Lilly And Company | 5-ht7 receptor antagonists |
| BR112012026530B1 (pt) | 2010-04-16 | 2018-03-20 | Bayer Intellectual Property Gmbh | Compostos heterocíclicos como pesticidas, composição os compreendendo e suas utilizações, bem como método para controle de pragas de pragas |
| CA2849385A1 (en) | 2011-10-11 | 2013-04-18 | Ucb Pharma, S.A. | 2-oxo-piperidinyl derivatives |
| FR2995605B1 (fr) | 2012-09-18 | 2014-09-19 | Sanofi Sa | Derives de macrolides, leur preparation et leur application therapeutique. |
| US10351535B2 (en) * | 2013-12-20 | 2019-07-16 | Esteve Pharmaceuticals, S.A. | Piperazine derivatives having multimodal activity against pain |
| US11505529B2 (en) | 2017-03-03 | 2022-11-22 | National Taiwan University | 8-phenyl-isoquinolines and pharmaceutical composition thereof used in the treatment of irritable bowel syndrome |
| KR102014335B1 (ko) * | 2017-12-01 | 2019-08-26 | 한국과학기술연구원 | 5-ht7 수용체의 조절제로 작용하는 아릴피라졸릴피페라진 또는 아릴피라졸릴다이아제페인의 유도체 및 이를 포함하는 중추신경계 질환 치료 또는 예방용 약학 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1149195C (zh) * | 1999-02-10 | 2004-05-12 | 伊莱利利公司 | 5－ht1f激动剂 |
| US20030008880A1 (en) * | 2001-05-02 | 2003-01-09 | Pfizer Inc. | 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity |
| US7153858B2 (en) * | 2003-01-31 | 2006-12-26 | Epix Delaware, Inc. | Arylpiperazinyl compounds |
| CA2514656A1 (en) * | 2003-01-31 | 2004-08-12 | Pfizer Products Inc. | 5ht7 antagonists and inverse agonists |
-
2008
- 2008-08-01 TW TW097129418A patent/TW200914020A/zh unknown
- 2008-08-19 AU AU2008293715A patent/AU2008293715B2/en not_active Ceased
- 2008-08-19 BR BRPI0816468 patent/BRPI0816468A2/pt not_active Application Discontinuation
- 2008-08-19 KR KR1020107004378A patent/KR101148616B1/ko not_active IP Right Cessation
- 2008-08-19 CN CN2008801048354A patent/CN101790522B/zh not_active Expired - Fee Related
- 2008-08-19 US US12/447,546 patent/US8048884B2/en not_active Expired - Fee Related
- 2008-08-19 PL PL08798144T patent/PL2188268T3/pl unknown
- 2008-08-19 JP JP2010523034A patent/JP5290293B2/ja not_active Expired - Fee Related
- 2008-08-19 CA CA2694911A patent/CA2694911C/en not_active Expired - Fee Related
- 2008-08-19 AT AT08798144T patent/ATE520673T1/de active
- 2008-08-19 EP EP08798144A patent/EP2188268B1/en not_active Not-in-force
- 2008-08-19 WO PCT/US2008/073543 patent/WO2009029439A1/en active Application Filing
- 2008-08-19 EA EA201070321A patent/EA017809B1/ru not_active IP Right Cessation
- 2008-08-19 SI SI200830392T patent/SI2188268T1/sl unknown
- 2008-08-19 DK DK08798144.5T patent/DK2188268T3/da active
- 2008-08-19 PT PT08798144T patent/PT2188268E/pt unknown
- 2008-08-19 MX MX2010002352A patent/MX2010002352A/es active IP Right Grant
- 2008-08-27 PE PE2008001449A patent/PE20090629A1/es not_active Application Discontinuation
- 2008-08-27 AR ARP080103721A patent/AR068111A1/es unknown
-
2011
- 2011-08-30 HR HR20110624T patent/HRP20110624T1/hr unknown
- 2011-09-20 CY CY20111100910T patent/CY1111848T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2010002352A (es) | 2010-08-04 |
| SI2188268T1 (sl) | 2011-11-30 |
| JP2010537994A (ja) | 2010-12-09 |
| EA017809B1 (ru) | 2013-03-29 |
| JP5290293B2 (ja) | 2013-09-18 |
| AU2008293715B2 (en) | 2013-09-19 |
| CN101790522B (zh) | 2012-06-27 |
| CY1111848T1 (el) | 2015-10-07 |
| BRPI0816468A2 (pt) | 2015-03-24 |
| CN101790522A (zh) | 2010-07-28 |
| CA2694911C (en) | 2013-05-07 |
| EP2188268B1 (en) | 2011-08-17 |
| EA201070321A1 (ru) | 2010-08-30 |
| US8048884B2 (en) | 2011-11-01 |
| CA2694911A1 (en) | 2009-03-05 |
| KR101148616B1 (ko) | 2012-05-21 |
| TW200914020A (en) | 2009-04-01 |
| ATE520673T1 (de) | 2011-09-15 |
| HRP20110624T1 (hr) | 2011-09-30 |
| WO2009029439A1 (en) | 2009-03-05 |
| US20100075976A1 (en) | 2010-03-25 |
| KR20100038117A (ko) | 2010-04-12 |
| EP2188268A1 (en) | 2010-05-26 |
| AR068111A1 (es) | 2009-11-04 |
| PE20090629A1 (es) | 2009-05-16 |
| PT2188268E (pt) | 2011-10-03 |
| PL2188268T3 (pl) | 2011-12-30 |
| AU2008293715A1 (en) | 2009-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2049478T3 (da) | Substituerede N-phenylmethyl-5-oxoprolin-2-amider som P2X7-receptorantagonister og fremgangsmåder til anvendelse deraf | |
| LTC2170860I2 (lt) | Benzimidazolo dariniai | |
| DK1718641T3 (da) | Benzimidazolderivat og dets anvendelse som All-receptorantagonist | |
| DK2170864T3 (da) | Pyridon-GPR119-G-protein-koblede receptoragonister | |
| DK2401269T3 (da) | Indolderivater som crth2-receptorantagonister | |
| DK2170828T3 (da) | Substituerede n-aryl pyridinoner som fibrotiske inhibitorer | |
| DK2162131T3 (da) | Quinolin-derivativer som pi3-kinase-inhibitorer | |
| DK2231614T3 (da) | Quinolinderivativer og anvendelse af disse som fungicider | |
| BRPI0910118A2 (pt) | antagonistas de receptores do glucagon | |
| DK1973886T3 (da) | Prokineticin-1-receptor-antagonister | |
| DK2188268T3 (da) | Substituerede piperazinylpyraziner og pyridiner som 5-HT7-receptorantagonister | |
| DK2094709T3 (da) | Thiazol-pyrazolopyrimidiner som CRF1-receptorantagonister | |
| DK2081951T3 (da) | Progesteron-receptorantagonister | |
| DK2155717T3 (da) | 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl-pyraziner og -pyridiner og 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl-pyridiner som 5-ht7-receptorantagonister | |
| BRPI0817245A2 (pt) | Derivados e quinolina como antagonistas receptores de 5ht5a | |
| DK2238110T3 (da) | 5.6-bisaryl-2-pyridin-carboxamid-derivater, fremstilling heraf og terapeutisk anvendelse heraf som urotensin II-receptorantagonister | |
| DK2401270T3 (da) | Pyrazolderivater anvendt som CCR4-receptorantagonister. | |
| DK2799428T3 (da) | Glucagon-antagonister | |
| DK2069310T3 (da) | Sulfonylpyrazolin-1-carboxamidin-derivater som 5-HT6-antagonister | |
| DK2059508T3 (da) | 5,6-bisaryl-2-pyridin-carboxamidderivater, fremstilling deraf og terapeutisk anvendelse deraf som urotensin II-receptorantagonister | |
| DK2205558T3 (da) | Substituterede n-phenylpyrrolidinylmethylpyrrolidinamider og terapeutisk anvendelse deraf som histamin-h3- receptormodulatorer | |
| DK2205569T3 (da) | Alkylthiopyrimidiner som crth2-antagonister | |
| BRPI0921437A2 (pt) | antagonistas da via do hedgehog á base de fitalazina dissubstituída | |
| BRPI0817835A2 (pt) | Antagonistas cgrp | |
| ATE534628T1 (de) | Urotensin ii-rezeptorantagonisten |